AUSTIN, Texas, Feb. 11, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public ...

This will be our third local news team; this one will produce investigative, data and engagement journalism to serve ...

Clearside Biomedical (CLSD) announces that two subgroup analyses were presented from the ODYSSEY Phase 2b clinical trial at the Angiogenesis, ...